Sat.Jul 20, 2024 - Fri.Jul 26, 2024

article thumbnail

This week in drug discovery (22-26 July) 

Drug Discovery World

News round-up for 22-26 July by DDW Senior Digital Content Editor Diana Spencer. There have been some interesting developments in neuroscience this week. Perhaps most note-worthy, shingles vaccines Shingrix has been shown to reduce the risk of dementia by 17%, and TikoMed’s ALS drug caused a long-term slowing of ALS progression in a Phase II trial. The top stories: Oxford centre to address global epilepsy challenges The University of Oxford is launching The Centre for Global Epilepsy to address

Vaccine 130
article thumbnail

Scientists assess how large dinosaurs could really get

Science Daily: Pharmacology News

A study looks at the maximum possible sizes of dinosaurs, using the carnivore, Tyrannosaurus rex, as an example. Using computer modelling, experts produced estimates that T. Rex might have been 70% heavier than what the fossil evidence suggests.

143
143
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study Finds Big Shift in Who's Using GLP-1 Meds Like Ozempic

Drugs.com

TUESDAY, July 23, 2024 -- The boom in using GLP-1 drugs like Ozempic to treat obesity has resulted in a bust regarding the drugs’ original purpose, which was to treat type 2 diabetes, a new study finds. New prescriptions for these drugs have d.

Drugs 119
article thumbnail

The Curse of Perfection – Toil and Trouble

Perficient: Drug Development

“Double, double toil and trouble,” is a line repeated by the witches in Macbeth as they lay out the ominous prophecies of greatness and dire consequences for the titular character. Macbeth’s ambition envisions a perfect ending though desperate actions and moral weakness ruin it. So too are the misguided actions in pursuit of perfection which can set expectations and pressure that lead to unwanted results.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Novartis and Dren Bio partner on bispecific antibodies for cancer

Drug Discovery World

Dren Bio and Novartis Pharma have entered a strategic collaboration focused on the discovery and development of therapeutic bispecific antibodies for cancer. Under the terms of the agreement, Dren Bio will receive a total upfront consideration of $150 million from Novartis, which includes a $25 million equity investment in the company. Dren Bio is also eligible to receive up to $2.85 billion in additional cash payments upon achieving certain preclinical, clinical, regulatory, and commercial mile

Therapies 130
article thumbnail

New study shows at-home colon cancer screening test reduces risk of colorectal cancer death, as effective as screening colonoscopy

Science Daily: Pharmacology News

A noninvasive colorectal cancer screening test that can be done at home could reduce the risk of colorectal cancer death by 33%, according to a new study.

142
142

More Trending

article thumbnail

Bird Flu Is Now Transmitting Mammal-to-Mammal: Study

Drugs.com

THURSDAY, July 25, 2024 -- The bird flu is now jumping between species of mammals, a step that draws the virus closer to hopping into human beings, a new study warns.Researchers have tracked transmission of avian influenza between dairy cows in.

Virus 116
article thumbnail

Podcast: Where is the global innovation and the opportunity in CGTs?

Drug Discovery World

This is the latest episode of the free DDW narrated podcast, titled “How to utilise clinical trials in drug discovery” which covers five articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: The promise and growth of cell and gene therapies No sign of stopping: The rise of cell and gene therapy Expert view: What’s next for cell and gene therapy?

Therapies 130
article thumbnail

Researchers develop state-of-the-art device to make artificial intelligence more energy efficient

Science Daily: Pharmacology News

Engineering researchers have demonstrated a state-of-the-art hardware device that could reduce energy consumption for artificial intelligent (AI) computing applications by a factor of at least 1,000.

Research 137
article thumbnail

Sanofi’s immunology bet starts to pay off

BioPharma Drive: Drug Pricing

Some analysts described Sanofi’s pipeline of immune system therapies, which includes more than half a dozen drugs in mid- to late-stage testing, as “underappreciated” by investors, as sales of Dupixent rose over the last quarter.

Therapies 115
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Certain Abbott Blood Sugar Monitors May Give Incorrect Readings

Drugs.com

FRIDAY, July 26, 2024 -- Abbott has warned diabetes patients that some of its continuous blood sugar monitoring systems may need to be replaced because of inaccurate readings."Abbott has recently identified a small number of FreeStyle Libre 3.

116
116
article thumbnail

Where is the global innovation and the opportunity in CGTs?

Drug Discovery World

This is the latest episode of the free DDW narrated podcast, titled “How to utilise clinical trials in drug discovery” which covers five articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: The promise and growth of cell and gene therapies No sign of stopping: The rise of cell and gene therapy Expert view: What’s next for cell and gene therapy?

article thumbnail

Smell of human stress affects dogs' emotions leading them to make more pessimistic choices

Science Daily: Pharmacology News

Dogs experience emotional contagion from the smell of human stress, leading them to make more 'pessimistic' choices, new research finds. Researchers tested how human stress odors affect dogs' learning and emotional state.

Research 129
article thumbnail

FDA Releases Draft Guidance on Essential Drug Delivery Outputs

FDA Law Blog: Biosimilars

By Adrienne R. Lenz, Principal Medical Device Regulation Expert — For several years, FDA has requested that sponsors of drug or biologic led combination products identify essential performance requirements (EPRs) related to the device constituent in their applications. EPRs were usually requested in the context of design controls, although 21 C.F.R. § 820.30 does not use this term.

FDA 105
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

'Two-Target' Antibiotics Could Make Bacterial Resistance Much Tougher

Drugs.com

THURSDAY, July 25, 2025 -- Synthetic antibiotics that attack bacteria in two directions at once could be the solution for combatting antimicrobial-resistant bugs, a new study claims.These dual-action antibiotics, called macrolones, disrupt.

116
116
article thumbnail

Study reveals how cancer cells metastasise to the liver

Drug Discovery World

Researchers at ETH Zurich in Switzerland have uncovered how colorectal cancer cells colonise the liver. The findings, by Andreas Moor in the Department of Biosystems Science and Engineering and his team, will help to develop treatments with which they hope could hinder the metastatic process. Cancer metastasises when cells from the primary tumour break off and travel via the circulatory system to other parts of the body.

article thumbnail

New drug shows promise in clearing HIV from brain

Science Daily: Pharmacology News

An experimental drug originally developed to treat cancer may help clear HIV from infected cells in the brain, according to a new study. By targeting infected cells in the brain, drug may clear virus from hidden areas that have been a major challenge in HIV treatment.

Virus 141
article thumbnail

The Role of Data Monitoring Committees (DMC) in Clinical Trials

Quanticate

Throughout the conduct of a clinical trial, ensuring patient safety and maintaining the integrity of the study are vital. This is where, Data Monitoring Committees (DMC) are used to support patient safety and integrity.

article thumbnail

Daily Supplements May Slow 'Dry' Form of Macular Degeneration

Drugs.com

MONDAY, July 22, 2024 -- Daily supplements can slow loss of vision related to late-stage “dry” age-related macular degeneration (AMD), a new study finds.The rate of dry AMD progression into a key eye region slowed by about 55% over an average three.

116
116
article thumbnail

Researchers identify potential new genetic target for cancer drugs

Drug Discovery World

UK researchers have mapped the exact variants in a gene that dramatically increase a person’s risk of developing cancer, paving the way for targeted treatment across diverse populations. Over 5,000 genetic variants that enable certain cancers to thrive were identified, along with a potential therapeutic target to treat or even prevent these cancers from developing.

Research 130
article thumbnail

A recipe for zero-emissions fuel: Soda cans, seawater, and caffeine

Science Daily: Pharmacology News

Engineers discovered that when the aluminum in soda cans is purified and mixed with seawater, the solution produces hydrogen -- which can power an engine or fuel cell without generating carbon emissions. The reaction can be sped up by adding caffeine.

article thumbnail

Understanding the Patent Trial and Appeal Board (PTAB) – A Comprehensive Overview

Drug Patent Watch

The Patent Trial and Appeal Board (PTAB) is a crucial component of the United States Patent and Trademark Office (USPTO), established in 2012 by the Leahy-Smith America Invents Act (AIA).

Trials 105
article thumbnail

Shingles Vaccine, Shingrix, Could Lower Dementia Risk

Drugs.com

FRIDAY, July 26, 2024 -- Older people who avail themselves of the newest shingles vaccine could reap a hidden benefit: A significant drop in their odds of developing dementia. One expert applauded the new findings. "Dementia isn’t an.

Vaccine 111
article thumbnail

Where are the global hotspots for biotech?

Drug Discovery World

The future is looking rosy for the biotechnology sector. Diana Spencer takes a world-tour of some of the key centres of innovation. According to data analysts Precedence Research, the global biotechnology market was estimated at $1.38 trillion in 2023 and is expected to be worth around $4.25 trillion by 2033, growing at an impressive CAGR of 11.8% 1.

article thumbnail

Chimpanzees gesture back and forth quickly like in human conversations

Science Daily: Pharmacology News

When people are having a conversation, they rapidly take turns speaking and sometimes even interrupt. Now, researchers who have collected the largest ever dataset of chimpanzee 'conversations' have found that they communicate back and forth using gestures following the same rapid-fire pattern.

Research 129
article thumbnail

#WhyIScience Q&A: A mechanical engineer builds microscopes to give new spatial views of cells and tissues

Broad Institute

#WhyIScience Q&A: A mechanical engineer builds microscopes to give new spatial views of cells and tissues By Leah Eisenstadt July 23, 2024 Breadcrumb Home #WhyIScience Q&A: A mechanical engineer builds microscopes to give new spatial views of cells and tissues Lindsey Erion-Barner describes her efforts to develop and share innovative tools in the Spatial Technology Platform By Leah Eisenstadt July 23, 2024 Credit: Allison Colorado, Broad Communications Lindsey Erion-Barner develops and shares

article thumbnail

Big Drop in U.S. Kids, Teens Misusing Prescription Meds

Drugs.com

WEDNESDAY, July 24, 2024 -- Misuse of illicit prescription drugs is falling dramatically among U.S. high school students, a new study says.The percentage of seniors who say they’ve misused prescription drugs in the past year has dropped to 2% in 2.

Drugs 115
article thumbnail

Abiologics launches with a new class of supranatural medicines

Drug Discovery World

Abiologics, a Flagship Pioneering company, has launched to develop a new class of supranatural and programmable medicines called Synteins. Synteins are computationally-generated and synthesised with novel building blocks, potentially providing treatments across a wide range of diseases. Flagship has initially committed $50 million to advance the company’s platform and develop a diverse pipeline of medicines, with an initial focus on oncology and immunology indications.

Treatment 130
article thumbnail

'Dancing molecules' heal cartilage damage

Science Daily: Pharmacology News

New therapy uses synthetic nanofibers to mimic the natural signaling of a protein that is crucial for cartilage formation and maintenance. Researchers found that intensifying the motion of molecules within the nanofibers led to more components needed for regeneration. After just four hours, the treatment activated the gene expression necessary to generate cartilage.

Therapies 125
article thumbnail

Celebrating Amarender Peddamalku’s Second Microsoft MVP Award

Perficient: Drug Development

Perficient is thrilled to announce that Amarender Peddamalku has been awarded the prestigious “Most Valuable Professional” (MVP) status in Business Applications by Microsoft for the second time. This achievement is especially significant, highlighting his continued excellence and commitment to the Microsoft community. Amarender Peddamalku serves as the Microsoft Modern Work practice lead and digital transformation leader at Perficient.

article thumbnail

FLiRTy Summer: All You Need to Know About the Latest COVID Variants

Drugs.com

SUNDAY, July 21, 2024 -- As yet another batch of variants fuel a COVID surge this summer, one expert offers advice on how to navigate the threat.“We've seen a bit of a seasonal pattern emerge, where we've had an uptick in COVID in the summer and t.

119
119
article thumbnail

SynaptixBio and Evotec extend rare disease therapies partnership

Drug Discovery World

SynaptixBio and Evotec have announced they are extending their partnership to find further candidate drugs to treat H-ABC, the most severe form of TUBB4A leukodystrophy. The drug research was originally carried out by the Children’s Hospital of Philadelphia (CHOP), the world’s leading centre for leukodystrophy research, under a sponsored research agreement.

Therapies 130
article thumbnail

Breakthrough in skeletal muscle regeneration

Science Daily: Pharmacology News

In a finding that opens the door to the development of targeted therapies for various muscle disorders, newly published research identifies key mechanisms of skeletal muscle regeneration and growth of muscles following resistance exercise.

Therapies 131
article thumbnail

To address the fentanyl crisis, greater access to methadone Is needed

National Institute on Drug Abuse: Nora's Blog

To address the fentanyl crisis, greater access to methadone Is needed area Mon, 07/22/2024 - 12:43 Nora's Blog July 29, 2024 By Nora D. Volkow, National Institute on Drug Abuse Image ©Getty images/ seb_ra Over the past several years, the increasing prevalence of fentanyl in the drug supply has created an unprecedented overdose death rate and other devastating consequences.